Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas

NEXT STORY
Plasma Fractionation Market Research Report by Product, by Application, by End User, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19
PREV STORY
atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19  

author_avatar
NASDAQ Market News

NEC Society Announces Nation’s First Necrotizing Enterocolitis Symposium Hosted in Partnership With the UC Davis Department of Pediatrics and Division of Neonatology

DALLAS, TX--(Marketwired - Feb 7, 2017) - NEC Society, the world's first and only ...

author_avatar
NASDAQ Market News

OncoMed Announces Multiple Abstracts Related to Anti-TIGIT Program Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2017

REDWOOD CITY, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) will ...

author_avatar
NASDAQ Market News